Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Vaxcyte (PCVX) Other Gross PP&E Adjustments (2019 - 2026)

Vaxcyte (PCVX) has 8 years of Other Gross PP&E Adjustments data on record, last reported at -$113.1 million in Q1 2026.

  • On a quarterly basis, Other Gross PP&E Adjustments fell 24.5% to -$113.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$113.1 million, a 24.5% decrease, with the full-year FY2025 number at $151.3 million, up 18.63% from a year prior.
  • Other Gross PP&E Adjustments reached -$113.1 million in Q1 2026 per PCVX's latest filing, down from $151.3 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for PCVX hit a ceiling of $151.3 million in Q4 2025 and a floor of -$113.1 million in Q1 2026.
  • A 5-year average of $12.7 million and a median of -$1.5 million in 2023 define the central range for Other Gross PP&E Adjustments.
  • Peak YoY movement for Other Gross PP&E Adjustments: plummeted 266.77% in 2022, then skyrocketed 9214.83% in 2024.
  • Tracing PCVX's Other Gross PP&E Adjustments over 5 years: stood at -$16.4 million in 2022, then surged by 398.35% to $48.9 million in 2023, then skyrocketed by 160.76% to $127.6 million in 2024, then rose by 18.63% to $151.3 million in 2025, then tumbled by 174.74% to -$113.1 million in 2026.
  • Business Quant data shows Other Gross PP&E Adjustments for PCVX at -$113.1 million in Q1 2026, $151.3 million in Q4 2025, and -$83.5 million in Q3 2025.